BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 12894700)

  • 1. [Recent progress in the treatment of acute leukemia].
    Kimura Y
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the treatment of adults with acute lymphoblastic leukemia.
    Larson S; Stock W
    Curr Opin Hematol; 2008 Jul; 15(4):400-7. PubMed ID: 18536580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology and therapy of adult acute lymphoblastic leukemia.
    Faderl S; Jeha S; Kantarjian HM
    Cancer; 2003 Oct; 98(7):1337-54. PubMed ID: 14508819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
    Harada M
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current therapeutic strategies in acute lymphoblastic leukemia in the adult].
    Thomas X; Le QH
    Bull Cancer; 2003 Oct; 90(10):833-50. PubMed ID: 14706913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lestingi TM; Hooberman AL
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):161-75. PubMed ID: 8449857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
    Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K;
    Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
    Kalaycio M; Advani A; Pohlman B; Sekeres M; Tripp B; Rybicki L; Sobecks R
    Am J Hematol; 2008 Nov; 83(11):831-4. PubMed ID: 18756545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of acute and chronic leukemias].
    Mandelli F; Montefusco E
    Recenti Prog Med; 1999 Nov; 90(11):605-12. PubMed ID: 10608151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Bao L; Jiang B; Huang XJ; Wang DB; Qiu JY; Lu XJ; Chen H; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):31-4. PubMed ID: 15946506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
    Takeuchi J
    Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
    Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
    Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of acute leukemia in adults].
    Lechner K
    Wien Med Wochenschr; 1991; 141(9-10):180-90. PubMed ID: 1949839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of priming with granulocyte macrophage colony-stimulating factor plus all-trans retinoic acid combined with remission induction chemotherapy in patients with acute myeloid leukemia.
    Shin HJ; Chung JS; Choi YJ; Cho GJ
    Am J Clin Oncol; 2009 Jun; 32(3):227-32. PubMed ID: 19433969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in the treatment and prognosis of adult leukemia with characteristics of patients in Japan: transition during the fifteen years from 1971 to 1985.
    Suzuki H; Ota K; Ohno R; Masaoka T; Shibata H; Kimura I; Amaki I; Miura Y; Uzuka Y; Kawato M
    Jpn J Clin Oncol; 1989 Dec; 19(4):338-47. PubMed ID: 2607637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of 32 cases of acute leukemia with abnormality of chromosome 7].
    Lu Y; Jin J; Chen ZM; Lou JY; Xu WL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):596-9. PubMed ID: 15583990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
    J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New agents for the treatment of acute myeloid leukemia.
    Tallman MS
    Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.